Related references
Note: Only part of the references are listed.Evaluating Multisite rCBV Consistency from DSC-MRI Imaging Protocols and Postprocessing Software Across the NCI Quantitative Imaging Network Sites Using a Digital Reference Object (DRO)
Laura C. Bell et al.
TOMOGRAPHY (2019)
Spatial discrimination of glioblastoma and treatment effect with histologically-validated perfusion and diffusion magnetic resonance imaging metrics
Melissa A. Prah et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Quantitative comparison of delayed ferumoxytol T1 enhancement with immediate gadoteridol enhancement in high grade gliomas
Andrea Horvath et al.
MAGNETIC RESONANCE IN MEDICINE (2018)
Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project
K. M. Schmainda et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2018)
Optimization of Acquisition and Analysis Methods for Clinical Dynamic Susceptibility Contrast MRI Using a Population-Based Digital Reference Object
N. B. Semmineh et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2018)
Effects of MRI Protocol Parameters, Preload Injection Dose, Fractionation Strategies, and Leakage Correction Algorithms on the Fidelity of Dynamic-Susceptibility Contrast MRI Estimates of Relative Cerebral Blood Volume in Gliomas
K. Leu et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2017)
MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis
Praneil Patel et al.
NEURO-ONCOLOGY (2017)
A Population-Based Digital Reference Object (DRO) for Optimizing Dynamic Susceptibility Contrast (DSC)-MRI Methods for Clinical Trials
Natenael B. Semmineh et al.
TOMOGRAPHY (2017)
Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma
Jerrold L. Boxerman et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2017)
Improved Leakage Correction for Single-Echo Dynamic Susceptibility Contrast Perfusion MRI Estimates of Relative Cerebral Blood Volume in High-Grade Gliomas by Accounting for Bidirectional Contrast Agent Exchange
K. Leu et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI
Elizabeth R. Gerstner et al.
CLINICAL CANCER RESEARCH (2016)
Bidirectional Contrast agent leakage correction of dynamic susceptibility contrast (DSC)-MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab
Kevin Leu et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2016)
Assessment of a simplified spin and gradient echo (sSAGE) approach for human brain tumor perfusion imaging
Ashley M. Stokes et al.
MAGNETIC RESONANCE IMAGING (2016)
Spiral Perfusion Imaging With Consecutive Echoes (SPICE™) for the Simultaneous Mapping of DSC- and DCE-MRI Parameters in Brain Tumor Patients: Theory and Initial Feasibility
Eric S. Paulson et al.
TOMOGRAPHY (2016)
Repeatability of Standardized and Normalized Relative CBV in Patients with Newly Diagnosed Glioblastoma
M. A. Prah et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2015)
Diffusion and Perfusion MRI to Differentiate Treatment-Related Changes Including Pseudoprogression from Recurrent Tumors in High-Grade Gliomas with Histopathologic Evidence
A. J. Prager et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2015)
Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma
L. S. Hu et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2015)
ASFNR Recommendations for Clinical Performance of MR Dynamic Susceptibility Contrast Perfusion Imaging of the Brain
K. Welker et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2015)
Association of dynamic susceptibility contrast enhanced MR Perfusion parameters with prognosis in elderly patients with glioblastomas
Pejman Jabehdar Maralani et al.
EUROPEAN RADIOLOGY (2015)
MRI perfusion measurements calculated using advanced deconvolution techniques predict survival in recurrent glioblastoma treated with bevacizumab
Robert J. Harris et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial
Kathleen M. Schmainda et al.
NEURO-ONCOLOGY (2015)
Relative cerebral blood volume is a potential predictive imaging biomarker of bevacizumab efficacy in recurrent glioblastoma
Philipp Kickingereder et al.
NEURO-ONCOLOGY (2015)
Association of overall survival in patients with newly diagnosed glioblastoma with contrast-enhanced perfusion MRI: Comparison of intraindividually matched T1- and T2*-based bolus techniques
David Bonekamp et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2015)
Assessing tumor cytoarchitecture using multiecho DSC-MRI derived measures of the transverse relaxivity at tracer equilibrium (TRATE)
Natenael B. Semmineh et al.
MAGNETIC RESONANCE IN MEDICINE (2015)
Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma
Kathleen M. Schmainda et al.
NEURO-ONCOLOGY (2014)
Parametric Response Maps of Perfusion MRI May Identify Recurrent Glioblastomas Responsive to Bevacizumab and Irinotecan
Domenico Aquino et al.
PLOS ONE (2014)
Which Combination of MR Imaging Modalities Is Best for Predicting Recurrent Glioblastoma? Study of Diagnostic Accuracy and Reproducibility
Ho Sung Kim et al.
RADIOLOGY (2014)
Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab
Kevin Leu et al.
CANCER IMAGING (2014)
MRI perfusion in determining pseudoprogression in patients with glioblastoma
Robert J. Young et al.
CLINICAL IMAGING (2013)
Angiogenesis in Glioblastoma
Sunit Das et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The 39 steps: evading error and deciphering the secrets for accurate dynamic susceptibility contrast MRI
Lisa Willats et al.
NMR IN BIOMEDICINE (2013)
Correlations between Perfusion MR Imaging Cerebral Blood Volume, Microvessel Quantification, and Clinical Outcome Using Stereotactic Analysis in Recurrent High-Grade Glioma
L. S. Hu et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2012)
Does MR Perfusion Imaging Impact Management Decisions for Patients with Brain Tumors? A Prospective Study
C. P. Geer et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2012)
The Role of Preload and Leakage Correction in Gadolinium-Based Cerebral Blood Volume Estimation Determined by Comparison with MION as a Criterion Standard
J. L. Boxerman et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2012)
Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas
Benjamin M. Ellingson et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2012)
Combined spin- and gradient-echo perfusion-weighted imaging
Heiko Schmiedeskamp et al.
MAGNETIC RESONANCE IN MEDICINE (2012)
Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival
Leland S. Hu et al.
NEURO-ONCOLOGY (2012)
Diagnostic Dilemma of Pseudoprogression in the Treatment of Newly Diagnosed Glioblastomas: The Role of Assessing Relative Cerebral Blood Flow Volume and Oxygen-6-Methylguanine-DNA Methyltransferase Promoter Methylation Status
D. -S. Kong et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2011)
T1- and T2*-dominant extravasation correction in DSC-MRI: Part I-theoretical considerations and implications for assessment of tumor hemodynamic properties
Atle Bjornerud et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)
Prognostic value of perfusion MR imaging in patients with oligodendroglioma: A survival study
Z. Jiang et al.
JOURNAL OF NEURORADIOLOGY (2011)
Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging
Sean J. Hipp et al.
NEURO-ONCOLOGY (2011)
Improved Perfusion MR Imaging Assessment of Intracerebral Tumor Blood Volume and Antiangiogenic Therapy Efficacy in a Rat Model with Ferumoxytol
Seymur Gahramanov et al.
RADIOLOGY (2011)
Optimized Preload Leakage-Correction Methods to Improve the Diagnostic Accuracy of Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging in Posttreatment Gliomas
L. S. Hu et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2010)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Standardization of Relative Cerebral Blood Volume (rCBV) Image Maps for Ease of Both Inter- and Intrapatient Comparisons
Devyani Bedekar et al.
MAGNETIC RESONANCE IN MEDICINE (2010)
Changes in Relative Cerebral Blood Volume 1 Month after Radiation-Temozolomide Therapy Can Help Predict Overall Survival in Patients with Glioblastoma
Rajiv Mangla et al.
RADIOLOGY (2010)
Glioblastoma Multiforme Regional Genetic and Cellular Expression Patterns: Influence on Anatomic and Physiologic MR Imaging
Ramon F. Barajas et al.
RADIOLOGY (2010)
Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements
L. S. Hu et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2009)
Pseudoprogression and pseudoresponse in the treatment of gliomas
Dieta Brandsma et al.
CURRENT OPINION IN NEUROLOGY (2009)
A theoretical framework to model DSC-MRI data acquired in the presence of contrast agent extravasation
C. C. Quarles et al.
PHYSICS IN MEDICINE AND BIOLOGY (2009)
Posttreatment Recurrence of Malignant Brain Neoplasm: Accuracy of Relative Cerebral Blood Volume Fraction in Discriminating Low from High Malignant Histologic Volume Fraction
Emerson L. Gasparetto et al.
RADIOLOGY (2009)
Differentiation of Recurrent Glioblastoma Multiforme from Radiation Necrosis after External Beam Radiation Therapy with Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging
Ramon F. Barajas et al.
RADIOLOGY (2009)
Comparison of Dynamic Susceptibility-weighted Contrast-enhanced MR Methods: Recommendations for Measuring Relative Cerebral Blood Volume in Brain Tumors
Eric S. Paulson et al.
RADIOLOGY (2008)
Low-grade gliomas: Dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging - Prediction of patient clinical response
M Law et al.
RADIOLOGY (2006)
Improving the reliability of obtaining tumor hemodynamic parameters in the presence of contrast agent extravasation
CC Quarles et al.
MAGNETIC RESONANCE IN MEDICINE (2005)
Effects of echo time variation on perfusion assessment using dynamic susceptibility contrast MR imaging at 3 tesla
O Thilmann et al.
MAGNETIC RESONANCE IMAGING (2004)
Aspects on the accuracy of cerebral perfusion parameters obtained by dynamic susceptibility contrast MRI:: a simulation study
L Knutsson et al.
MAGNETIC RESONANCE IMAGING (2004)
Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps
MA Badruddoja et al.
NEURO-ONCOLOGY (2003)
Signal-to-noise ratio effects in quantitative cerebral perfusion using dynamic susceptibility contrast agents
MR Smith et al.
MAGNETIC RESONANCE IN MEDICINE (2003)
Share Paper
